Published March 2022 | Version Supplemental Material + Submitted
Journal Article Open

Synthetic logic circuits using RNA aptamer against T7 RNA polymerase

  • 1. ROR icon Pohang University of Science and Technology
  • 2. ROR icon California Institute of Technology
  • 3. ROR icon Columbia University
  • 4. ROR icon University of California, Santa Barbara

Abstract

Recent advances in nucleic acids engineering introduced several RNA-based regulatory components for synthetic gene circuits, expanding the toolsets to engineer organisms. In this work, we designed genetic circuits implementing an RNA aptamer previously described to have the capability of binding to the T7 RNA polymerase and inhibiting its activity in vitro. We first demonstrated the utility of the RNA aptamer in combination with programmable synthetic transcription networks in vitro. As a step to quickly assess the feasibility of aptamer functions in vivo, we tested the aptamer and its sequence variants in the cell-free expression system, verifying the aptamer functionality in the cell-free testbed. The expression of aptamer in E. coli demonstrated control over GFP expression driven by T7 RNA polymerase, indicating its ability to serve as building blocks for logic circuits and transcriptional cascades. This work elucidates the potential of T7 RNA polymerase aptamer as regulators for synthetic biological circuits and metabolic engineering.

Additional Information

© 2021 Wiley. Issue Online: 11 March 2022; Version of Record online: 29 April 2021; Accepted manuscript online: 04 April 2021; Manuscript accepted: 30 March 2021; Manuscript revised: 05 March 2021; Manuscript received: 21 October 2020. This work was supported by National Science Foundation award no. 0832824 (The Molecular Programming Project) and the Defense Advanced Research Projects Agency (DARPA/MTO) Living Foundries program, contract number HR0011-12-C-0065 (DARPA/CMO). The views and conclusions contained in this document are those of the authors and should not be interpreted as representing officially policies, either expressly or implied, of the Defense Advanced Research Projects Agency or the U.S. Government. The authors thank David Shis and Matthew Bennett for providing the pTara plasmid. Conflict of interest statement. None declared.

Attached Files

Submitted - 008771.full.pdf

Supplemental Material - biot202000449-sup-0001-suppmat.pdf

Files

008771.full.pdf

Files (6.8 MB)

Name Size Download all
md5:25edc4e993451bd25b766a9cac9b5035
2.1 MB Preview Download
md5:f6e39e037c710d026409f0cd680e0806
4.6 MB Preview Download

Additional details

Identifiers

Eprint ID
50017
Resolver ID
CaltechAUTHORS:20140925-085129247

Related works

Describes
10.1101/008771 (DOI)

Funding

NSF
CCF-0832824
Defense Advanced Research Projects Agency (DARPA)
HR0011-12-C-0065

Dates

Created
2016-05-14
Created from EPrint's datestamp field
Updated
2022-03-25
Created from EPrint's last_modified field

Caltech Custom Metadata

Caltech groups
Division of Biology and Biological Engineering (BBE)